China SXT Pharmaceuticals, Inc. (SXTC) Shareholders’ equity 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) shareholders’ equity at each fiscal year-end, per SEC filings.
$29.7MFY2026 · since FY2017: $1.9M → $29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $29.7M | +92.4% |
| FY2025 | $15.4M | +10.8% |
| FY2024 | $13.9M | -5.2% |
| FY2023 | $14.7M | -8.7% |
| FY2022 | $16.1M | +0.8% |
| FY2021 | $16.0M | +69.8% |
| FY2020 | $9.4M | -15.4% |
| FY2019 | $11.1M | +238.1% |
| FY2018 | $3.3M | +77.4% |
| FY2017 | $1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice